Skip to main content
Premium Trial:

Request an Annual Quote

MWG Biotech, Allegro Technologies, Bruker Daltonics, Amersham Biosciences, Telechem International

Premium

MWG Biotech of Ebersberg, Germany, has introduced EquatorT, a nanoliter pipetting system that is based on patented technology from Allegro Technologies, a liquid handling technology company based in Dublin, Ireland. The new instrument enables contact-free pipetting in a range from 50 nl to 20 ml at a speed of about 15 seconds for a 1,536 microplate.

 

Bruker Daltonics said it will launch a biomarker discovery product called ClinProt that will combine magnetic bead-based sample preparation with MALDI-TOF and MALDI-TOF/TOF analysis. Various types of beads, coated with normal phase, anionic, cationic, hydrophobic, or metal-ion surfaces, as well as customer-specified beads will be available. These selectively capture and enrich certain classes of peptides and proteins from serum or other biological samples. Sample preparation is done in a 96-well plate format using liquid handling robots, which deposit the samples onto AnchorChip target plates for MALDI mass spectrometry. ClinProt will be demonstrated at Bruker’s facilities and at the ASMS conference in Montreal in June.

 

Amersham Biosciences has introduced a new type of service contract called Your Agreement. It allows customers, through a questionnaire, to choose the length of the contract, response levels, coverage hours, preventative maintenance, parts covered, software upgrades, computer support, and training.

 

The ArrayIt division of Telechem International of Sunnyvale, Calif., is preparing to introduce a protein microarray platform that includes microarray manufacturing, processing, surface chemistry, detection reagents, scanning, and analysis. According to the company’s web site, http://www.arrayit.com the platform will be available by the end of this month.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.